Definitive Contract 75N93020C00018

Award Date 7/1/20

Potential Completion Date 8/31/25

Potential Value $31M

Federal Agency

National Institute of Allergy and Infectious Diseases

Awardee

Revagenix Inc.

Ultimate Awardee

Not listed

NAICS Category

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

PSC Category

AN12 - Health R&D Services; Health Care Services; Applied Research

Federal Contract Vehicle

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Cost Plus Fixed Fee

Place of Performance

San Diego, CA 92101, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Legislative Mandate

Employment Eligibility Verification

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This is a $31,055,094.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Revagenix Inc. The contract is for the development of a novel small molecule antibiotic, taking it through investigational new drug (IND) filing and Phase 1 clinical studies. The original solicitation was a Broad Agency Announcement seeking proposals for the development of radiation and nuclear medical countermeasures, with up to $4 million per year in funding available. This contract is not set aside for any specific business category.

Generated 12/13/24, 9:01 AM

Name	Solicitation Number	Federal Agency	Type	Posted Date (Click to sort descending)
2019 NIAID Omnibus Broad Agency Announcement	HHS-NIH-NIAID-BAA2019-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Pre-Solicitation 2/11	2/22/19, 3:54 PM
HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria	HHS-NIH-NIAID-BAA2019-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 10/11	8/28/20, 2:00 PM
HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria	HHS-NIH-NIAID-BAA2019-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 7/11	6/29/20, 8:37 PM
HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria	HHS-NIH-NIAID-BAA2019-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 8/11	6/29/20, 8:41 PM
HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria	HHS-NIH-NIAID-BAA2019-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 11/11	8/28/20, 2:10 PM

Mod #	Reason For Modification	Federal Obligation (Click to sort descending)	Date (Click to sort ascending)
P00018	Other Administrative Action	$0	12/12/24
P00017	Other Administrative Action	$0	8/16/24
P00016	Funding Only Action	$3.8m	8/1/24
P00015	Other Administrative Action	$0	7/10/24
P00014	Funding Only Action	$2.8m	2/23/24

Plans
Login

Blog